Falk Transformational Research Award
The Falk Transformational Award funds advanced biomedical research to help prior Catalyst Award projects overcome barriers and accelerate their translation into clinical treatments or commercial products.
Funder: Health Resources in Action
Due Dates: June 15, 2023 | June 4, 2026 (2:00 PM Eastern Time)
Funding Amounts: Up to $1,000,000 total (inclusive of 10% indirect costs) for 2–3 years
Summary: Provides additional funding to successful Catalyst Awardees to advance high-impact biomedical research toward commercialization and clinical translation.
Key Information: Only prior Falk Catalyst Award recipients are eligible; U.S. faculty appointment required.
Description
This program, managed by Health Resources in Action on behalf of the Dr. Ralph and Marian Falk Medical Research Trust, supports advanced biomedical research projects that have previously received Catalyst Awards. The Transformational Award is designed to help successful Catalyst projects overcome scientific and therapeutic roadblocks, accelerating progress toward new treatments and potential cures. Funding is intended to move promising innovations closer to commercial development and clinical application, with a focus on projects addressing critical unmet needs in human health.
